Why the study?
The relationship between pulse pressure and prognosis in patients with chronic coronary syndrome is contradictory.
Does intra-aortic pulse pressure measured before PCI predict major adverse cardiovascular events in patients with chronic coronary syndrome?
Does intra-aortic pulse pressure measured before PCI predict major adverse cardiovascular events in patients with chronic coronary syndrome?
Invasively measured intra-aortic pulse pressure before PCI provides prognostic information, with lower values independently predicting a higher risk of MACE at one year in patients with chronic coronary syndrome.
Answers are grounded in this paper and cite their sources.
May aid pre-PCI risk stratification in chronic coronary syndrome; leaves open whether IAPP measurement improves outcomes.
BACKGROUND: The relationship between pulse pressure and prognosis in patients with chronic coronary syndrome (CCS) is contradictory. In the present study, we aimed to examine the relationship between intra-aortic pulse pressure (IAPP) and major adverse cardiovascular events (MACE) in patients with CCS undergoing percutaneous coronary intervention (PCI). METHODS: A total of 139 CCS patients who underwent elective PCI with regular one-year follow-up, were stratified into two subgroups according to IAPP. The primary outcomes included the occurrence of MACE, defined as cardiovascular death, acute myocardial infarction with ST-segment elevation (STEMI), acute myocardial infarction without ST-segment elevation (NSTEMI), target vessel revascularization (TVR), and stroke. RESULTS: The mean age of the patients was 57.6 ± 10.4 years, 32% of whom were female. The mean IAPP, systolic blood pressure (SBP), and diastolic blood pressure (DBP) were 54.0 ± 17.6 mmHg, 129.7 ± 20 mmHg, and 75.8 ± 11.8 mmHg, respectively. SBP, IAPP, and left ventricular ejection fraction (LVEF) were significantly higher in the high IAPP group (p < .001, p < .001, p = .001, respectively). The MACE rate was significantly higher in the low IAPP group than in the high IAPP group (30.4% vs. 8.6%, p = 0,001). The LVEF (OR = 0.93, CI:0.88-0.99, p = .025) and IAPP (OR = 0.89, CI:0.83-0.95, p = .001) were found to be independent predictors of MACE. The IAPP value of 39.5 mmHg was identified as an effective cutoff point for prediction of MACE-free survival rates (AUC:0.853, CI:0.768-0.937). CONCLUSION: Invasively measured IAPP has prognostic information about cardiovascular outcomes in patients with CCS. The risk of MACE is significantly greater in CCS patients with low IAPP compared with those who have high IAPP values.
No takes yet. Share an insight, caveat, or question.
Aktaş et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: